Transcription Factors Regulating Inflammatory Cytokine Production Are Differentially Expressed in Peripheral Blood Mononuclear Cells of Behçet Disease Depending on Disease Activity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Behçet disease (BD) is a relapsing inflammatory disease with increased production of inflammatory cytokines in peripheral blood mononuclear cells (PBMCs); however, the underlying molecular mechanisms are not well known. Objective: To analyze whether the differential expression of transcription factors is involved in the increased tumor necrosis factor (TNF)-α and interleukin (IL)-6 production by PBMCs of BD patients compared to healthy controls (HCs). Methods: Expression of transcription factors was examined by real-time reverse transcriptase-polymerase chain reaction and western blotting. Cytokine production by CD11b+ cells transfected with siRNAs against transcription factors was measured by enzyme-linked immunosorbent assay. Results: In the absence of lipopolysaccharide stimulation, the transcript level of CCAAT-enhancer-binding proteins (C/EBP) β was increased in PBMCs from patients with active BD compared to that in PBMCs from patients with stable BD. The C/EBPδ transcript level was higher in PBMCs from patients with active BD than in those from HCs. The activating transcription factor 3 (ATF3) transcript level was increased in PBMCs from patients with stable BD compared to that in PBMCs from HCs. siRNAs targeting C/EBPβ and C/EBPδ significantly reduced the production of IL-6 and TNF-α in lipopolysaccharide-stimulated CD11b+ cells from patients with BD as well as from HCs. Conclusion: We found differential expression of C/EBPβ, C/EBPδ, and ATF3 in PBMCs from patients with BD depending on disease activity, indicating the involvement of these molecules in BD pathogenesis.
Abstract
Background: Behçet disease (BD) is a relapsing inflammatory disease with increased production of inflammatory cytokines in peripheral blood mononuclear cells (PBMCs); however, the underlying molecular mechanisms are not well known. Objective: To analyze whether the differential expression of transcription factors is involved in the increased tumor necrosis factor (TNF)-α and interleukin (IL)-6 production by PBMCs of BD patients compared to healthy controls (HCs). Methods: Expression of transcription factors was examined by real-time reverse transcriptase-polymerase chain reaction and western blotting. Cytokine production by CD11b+ cells transfected with siRNAs against transcription factors was measured by enzyme-linked immunosorbent assay. Results: In the absence of lipopolysaccharide stimulation, the transcript level of CCAAT-enhancer-binding proteins (C/EBP) β was increased in PBMCs from patients with active BD compared to that in PBMCs from patients with stable BD. The C/EBPδ transcript level was higher in PBMCs from patients with active BD than in those from HCs. The activating transcription factor 3 (ATF3) transcript level was increased in PBMCs from patients with stable BD compared to that in PBMCs from HCs. siRNAs targeting C/EBPβ and C/EBPδ significantly reduced the production of IL-6 and TNF-α in lipopolysaccharide-stimulated CD11b+ cells from patients with BD as well as from HCs. Conclusion: We found differential expression of C/EBPβ, C/EBPδ, and ATF3 in PBMCs from patients with BD depending on disease activity, indicating the involvement of these molecules in BD pathogenesis.
참고문헌 (14)
- Pineton de Chambrun M, "New insights into the pathogenesis of Behçet's disease", Autoimmun Rev, 11, pp.687~698 (2012)
- Sim JH, "Altered expression of costimulatory molecules in Behçet's disease according to clinical activity", Br J Dermatol, 164, pp.1285~1291 (2011)
- Mege JL, "Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects", J Rheumatol, 20, pp.1544~1549 (1993)
- Akman A, "TNF-alpha gene 1031 T", C polymorphism in Turkish patients with Behçet's disease, 2006, pp.155, 350~356
- Medzhitov R, "Transcriptional control of the inflammatory response", Nat Rev Immunol, 9, pp.692~703 (2009)
- Lu YC, "Differential role for c-Rel and C", EBPbeta, J Immunol, pp.2009, 182[DOI]
- Whitmore MM, "Negative regulation of TLR-signaling pathways by activating transcription factor-3", J Immunol, 179, pp.3622~3630 (2007)
- Cangemi R, "Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia", J Infect, 73, pp.107~114 (2016)
- Calkhoven CF, "Translational control of C", EBPalpha and C, Genes Dev, pp.2000, 14[DOI]
- Tsai VW, "CCAAT", enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease, 2011, pp.31, 17612~17621
- Dasgupta S, "Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells", J Biol Chem, 278, pp.22424~22431 (2003)
- Tsushima H, "CCAAT", enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis, 2012, pp.71, 99~107
- Lu D, "The regulation of ATF3 gene expression by mitogen-activated protein kinases", Biochem J, 401, pp.559~567 (2007)
- Pan YX, "Interaction of RNA-binding proteins HuR and AUF1 with the human ATF3 mRNA 3'-untranslated region regulates its amino acid limitationinduced stabilization", J Biol Chem, 280, pp.34609~34616 (2005)